Premium
1,4‐Bis[2‐(3,5‐dichloropyridyloxy)]benzene induces substantial hyperplasia in fibrotic mouse liver
Author(s) -
Bugyik Edina,
Dezső Katalin,
Turányi Eszter,
Szurián Kinga,
Paku Sándor,
Nagy Peter
Publication year - 2012
Publication title -
international journal of experimental pathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.671
H-Index - 72
eISSN - 1365-2613
pISSN - 0959-9673
DOI - 10.1111/j.1365-2613.2011.00803.x
Subject(s) - thioacetamide , hepatocyte , liver regeneration , fibrosis , cirrhosis , in vivo , cancer research , cell growth , hepatic fibrosis , medicine , hyperplasia , chemistry , pathology , endocrinology , biology , regeneration (biology) , microbiology and biotechnology , in vitro , biochemistry
Summary The proliferative response of hepatocytes in vivo can be induced by two mechanisms: severe damage to hepatic tissue results in regenerative growth and so‐called primary hepatocyte mitogens can initiate liver cell proliferation without preceding loss of parenchyma. The regulation of the two responses is quite different. The decreased regenerative response of cirrhotic/fibrotic liver is well known, and is a severe obstacle to surgery of the diseased liver. In the present experiments we investigated the efficiency of a primary hepatocyte mitogen 1,4‐Bis[2‐(3,5‐dichloropyridyloxy)]benzene (TCPOBOB) on two different liver cirrhosis/fibrosis models in mice induced by chronic administration of CCl 4 and thioacetamide respectively. BrdU incorporation and cyclin A expression established clearly that there is a reduced but still powerful mitogenic response of the fibrotic livers. Therefore, primary hepatocyte mitogens appear to be suitable to be used to rescue the regenerative response of cirrhotic livers.